Literature DB >> 28968150

Recurrent Respiratory Papillomatosis and Bevacizumab Treatment.

Sebastian Fernandez-Bussy1, Gonzalo Labarca2,3, Macarena R Vial1, Rodrigo Soto1, Hiren J Mehta4, Michael Jantz4, Adnan Majid5, Mauricio Burotto6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28968150     DOI: 10.1164/rccm.201702-0279LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

1.  Systemic and Intralesional Bevacizumab in Juvenile Onset Recurrent Respiratory Papillomatosis: A Report of Two Cases.

Authors:  Arun Goyal; Dhruv Kapoor; Richa Saha
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-08-18

Review 2.  Airway Papillomatosis: New Treatments for an Old Challenge.

Authors:  Nankee Kumar; Diego Preciado
Journal:  Front Pediatr       Date:  2019-09-18       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.